Cardiovascular disease risk after radiotherapy and anthracycline-based chemotherapy for diffuse large B-cell lymphoma

Journal:

Journal of the National Cancer Institute

Published:

2026-03-25

DOI:

10.1093/jnci/djag085

Affiliations:

30

Authors:

32

Go to article

Institutions	Authors	Share
Netherlands Cancer Institute (NKI), Netherlands	6.000000	0.19
Leiden University Medical Center (LUMC), Netherlands	2.000000	0.06
University Medical Center Utrecht (UMC Utrecht), Netherlands	2.000000	0.06
Amsterdam UMC, Location VUmc, Netherlands	2.000000	0.06
Radiotherapiegroep, Netherlands	2.000000	0.06
Erasmus University Medical Center (Erasmus MC), Netherlands	1.500000	0.05
Radboud University Medical Centre (Radboudumc), RU, Netherlands	1.000000	0.03
University Medical Center Groningen (UMCG), RUG, Netherlands	1.000000	0.03
Instituut Verbeeten - Tilburg, Netherlands	1.000000	0.03
St. Antonius Hospital, Netherlands	1.000000	0.03
Catharina Hospital, Netherlands	1.000000	0.03
Albert Schweitzer Hospital, Netherlands	1.000000	0.03
Medisch Spectrum Twente, Netherlands	1.000000	0.03
Medical Center Haaglanden (MCH), Netherlands	1.000000	0.03
Frisius MC, Netherlands	1.000000	0.03
HAGA Hospital, Netherlands	1.000000	0.03
Maastricht University Medical Center+ (Maastricht UMC+), Netherlands	1.000000	0.03
Noordwest Hospital Group, Netherlands	1.000000	0.03
Reinier de Graaf Hospital, Netherlands	1.000000	0.03
Adrz, Netherlands	1.000000	0.03
Zuidwest Radiotherapeutisch Instituut (ZRTI), Netherlands	1.000000	0.03
Amsterdam UMC, Location AMC, Netherlands	1.000000	0.03
Sanquin Blood Supply, Netherlands	0.500000	0.02

Interested in Cardiovascular Medicine and Haematology?